Full-Time

Machine Learning Research Engineer

Workflows/Systems

Achira

Achira

11-50 employees

Atomistic drug-discovery simulation platform

Compensation Overview

$164.6k - $259k/yr

San Francisco, CA, USA + 1 more

More locations: New York, NY, USA

Hybrid

Hybrid roles require time in the office; New York-based candidates travel to San Francisco as needed.

Category
AI & Machine Learning (1)
Required Skills
LLM
Git
PyTorch
Machine Learning
Data Engineering

Get referred to Achira

See people who can refer or advise you

Requirements
  • At least two years of relevant industry experience.
  • Fluency in and enthusiasm for PyTorch and JAX.
  • Experience thinking in asynchronous primitives.
  • Strong knowledge of library design, including clean abstractions, minimal surface area, and consistency.
  • A solid track record of observable artifacts, such as GitHub repositories, showing clear, well-documented code.
  • Generalist machine learning knowledge, including scalable and reliable machine learning systems.
Responsibilities
  • Build and maintain robust multi-stage asynchronous workflows for data generation, training, and evaluations for the machine learning stack.
  • Rationalize machine learning systems design and software architecture.
  • Identify blockers and build solutions that scale to the size of foundation models.
  • Operate as the connection between research scientists and the infrastructure team.
Desired Qualifications
  • Experience with equivariant architectures, geometric deep learning, or graph neural networks (NequIP, MACE, SchNet, PaiNN, or similar), and/or machine learning-assisted drug discovery.
  • Experience building in declarative workflow orchestration frameworks such as Flyte or Dagster.
  • Comfort interacting with quantum chemical scientists and their data pipelines.

Achira develops atomistic foundation simulation models for drug discovery, combining geometric deep learning, physics, quantum chemistry, and statistical mechanics to create advanced potentials and generative models. These models produce large synthetic datasets free from experimental artifacts, enabling true inverse design where researchers optimize compounds from desired properties. Achira serves pharmaceutical and biotech clients through partnerships, licensing, and collaborations, differentiating itself by integrating physics-based simulations with data-driven learning to mitigate data scarcity and high costs. The company's goal is to accelerate and make drug discovery more reliable by enabling inverse design that reduces time and expenses in identifying promising compounds.

Company Size

11-50

Company Stage

Seed

Total Funding

$33M

Headquarters

New York City, New York

Founded

2024

Get referred to Achira

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Achira announced a $33M raise from Dimension, NVIDIA, Amplify, and Compound.
  • June 2026 BIO collaboration with NVIDIA expands distribution into life-sciences discovery workflows.
  • Hiring across ML, backend, and distributed systems shows active platform buildout in San Francisco and New York.

What critics are saying

  • Achira is still a 2024 company; product-market fit remains unproven by 2026.
  • Six open roles signal heavy burn before meaningful customer revenue arrives.
  • If NVIDIA or pharma partnerships stall, Achira becomes a research project, not a business.

What makes Achira unique

  • Achira pairs atomistic foundation models with physics, quantum chemistry, and geometric deep learning.
  • Its models generate synthetic molecular data, reducing dependence on scarce, artifact-prone experiments.
  • NVIDIA collaboration on molecular world models gives Achira compute and credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Hybrid Work Options

Flexible Work Hours

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

PTO/vacation

Paid Vacation

Paid Holidays

Unlimited Paid Time Off

401(k) Retirement Plan

Stock Options

Company Equity

Wellness Program

Mental Health Support

Gym Membership

Conference Attendance Budget

Professional Development Budget

Phone/Internet Stipend

Home Office Stipend

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Confluence

Growth & Insights and Company News

Headcount

6 month growth

20%

1 year growth

20%

2 year growth

28%
The National Herald
Apr 10th, 2025
Achira AI Secures $33M in Funding

Greek startup Achira AI has secured $33 million in funding from top investors, including Dimension, Nvidia, Amplify, and Compound. Achira aims to revolutionize AI-enabled drug development by integrating geometric deep learning, physics, quantum chemistry, and statistical mechanics to create advanced simulation models. This approach seeks to overcome limitations in current biomolecular simulations and machine learning models, accelerating the discovery of new molecules and treatments.

Endpoints News
Feb 21st, 2025
Nvidia-backed Achira debuts, blending AI and physics to model molecules

As he was testing new antivirals to halt a future pandemic, John Chodera encountered an unlikely set of new problems that ultimately helped lead to his new job. The computational ...